These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9127632)

  • 1. Alteration of thymidine kinase activity in cells treated with an antiviral agent.
    Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F
    J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase.
    Antonelli G; Turriziani O; Verri A; Narciso P; Ferri F; D'Offizi G; Dianzani F
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):223-8. PubMed ID: 8835200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
    Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further study of the mechanism underlying the cellular resistance to AZT.
    Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F
    Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.
    Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine.
    Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G
    Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
    McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
    J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene.
    Gröschel B; Höver G; Doerr HW; Cinatl J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):487-92. PubMed ID: 11563064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
    Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
    Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.
    Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J
    Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine induces the expression of cellular resistance affecting its antiviral activity.
    Dianzani F; Antonelli G; Turriziani O; Riva E; Simeoni E; Signoretti C; Strosselli S; Cianfriglia M
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1471-8. PubMed ID: 7888202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
    Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine.
    Guettari N; Loubière L; Brisson E; Klatzmann D
    Virology; 1997 Sep; 235(2):398-405. PubMed ID: 9281520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine kinase and deoxycytidine kinase in HIV-infected children.
    Falasca F; Maida P; Boni A; Bernardi S; Cursi L; Rizzo B; Antonelli G; Gattinara GC; Turriziani O
    New Microbiol; 2009 Oct; 32(4):411-3. PubMed ID: 20128449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line.
    Turriziani O; Simeoni E; Dianzani F; Antonelli G
    Antivir Ther; 1998; 3(3):191-4. PubMed ID: 10682138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and cytotoxicity of therapeutic nucleoside analogues: a comparison of alpha and gamma herpesvirus thymidine kinase suicide genes.
    Cazaux C; Tiraby M; Loubiere L; Haren L; Klatzmann D; Tiraby G
    Cancer Gene Ther; 1998; 5(2):83-91. PubMed ID: 9570299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT.
    Egron D; Arzumanov AA; Dyatkina NB; Aubertin AM; Imbach JL; Gosselin G; Krayevsky A; Périgaud C
    Bioorg Chem; 2001 Dec; 29(6):333-44. PubMed ID: 11846432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
    Johnson S
    Med Hypotheses; 2001 Mar; 56(3):409-10. PubMed ID: 11359372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.